Send the following on WhatsApp
Continue to Chathttps://de.marketscreener.com/kurs/aktie/BIOMIND-LABS-INC-125277790/news/Biomind-Labs-Inc-gibt-die-FDA-Zulassung-fur-das-neue-Medikament-Triptax-153-zur-Behandlung-von-t-42317804/?utm_source=whatsapp&utm_medium=social&utm_campaign=share